Improving immunotherapy in solid tumors using FMT - PubMed
5 hours ago
- #Fecal Microbiota Transplantation
- #Immunotherapy
- #Solid Tumors
- FMT improves outcomes of immune checkpoint inhibitor therapy in renal cell carcinoma, melanoma, and non-small cell lung cancer.
- The benefit is linked to reshaping the microbiome, reducing harmful bacteria, and modulating immune and metabolic pathways.
- The research backs using microbiome-focused treatments to boost cancer immunotherapy.
- Authors hold patents for microbiome-related cancer treatments and disclose multiple industry ties, including advisory roles, consultancy, and research funding.